Being diagnosed with a retroperitoneal tumor requires expert medical care. In Ahmedabad, Dr. Swati Shah is well-known for her expertise in treating retroperitoneal tumors, providing the best robotic retroperitoneal tumor resection surgery in Ahmedabad, Gujarat, and across India. With over 15+ years of experience in tumor resection surgery and 10+ years in Robotic Surgery, Dr. Shah's use of advanced medical technologies has helped many patients successfully overcome this challenging condition.
11750+ Patients have been successfully treated
15+ years of work experience
as a Retroperitoneal Cancer specialist
24+ Awards received by Dr. Shah for her achievements
MS, DrNB (Surgical Oncology)
MS, DrNB (Surgical Oncology)
⦿ MS (General Surgery) : Maulana Azad Medical College, New Delhi
⦿ DrNB Surgical Oncology : Rajiv Gandhi Cancer Institute, New Delhi.
⦿ Training in Gynec Cancer Surgery & HIPEC from the pioneer institute for Gynec Cancer surgeries in New Delhi.
⦿ Laparoscopic Resection for Early-Stage Retroperitoneal Tumors
⦿ Open Resection for Advanced Retroperitoneal Sarcomas
⦿ Nephrectomy for Retroperitoneal Kidney Cancer
⦿ Adrenalectomy for Adrenal Gland Tumors
⦿ Cytoreductive Surgery for Retroperitoneal Metastasis
⦿ Robotic-Assisted Surgery for Retroperitoneal Tumors
Explore surgical videos & photographs with caution. Please be advised that viewer discretion is recommended.
Dr Swati Shah (Uro & Gynec Oncosurgeon) and Dr Harsh Shah (GI & HPB Oncosurgeon) have 15+ years of experience in performing retroperitoneal tumour surgeries.
Each case is analysed and discussed in multidisciplinary team (including Radiologist, Pathologist, other Oncologists). CT scan/ MRI/ PET scan and biopsy reports are studied in detail to plan the surgery.
Patient optimisation, fitness and care during surgery is managed by team of doctors. Expert Anaesthetists to manage such cases. Operation theatres are well equipped & OT staff & technicians are trained for such cases.
State of the art ICU & round the clock ICU team to make the post operative recovery smooth. Team of doctors including intensivists, physicians, cardiologists, chest physicians & physiotherapists is available.
Dr Swati Shah (Uro & Gynec Oncosurgeon) and Dr Harsh Shah (GI & HPB Oncosurgeon) have 15+ years of experience in performing retroperitoneal tumour surgeries.
Each case is analysed and discussed in multidisciplinary team (including Radiologist, Pathologist, other Oncologists). CT scan/ MRI/ PET scan and biopsy reports are studied in detail to plan the surgery.
Patient optimisation, fitness and care during surgery is managed by team of doctors. Expert Anaesthetists to manage such cases. Operation theatres are well equipped & OT staff & technicians are trained for such cases.
State of the art ICU & round the clock ICU team to make the post operative recovery smooth. Team of doctors including intensivists, physicians, cardiologists, chest physicians & physiotherapists is available.
| Factor | Retroperitoneal Tumor Resection | Chemotherapy | Radiation Therapy | Observation |
|---|---|---|---|---|
| Tumor Removal | Complete removal possible in most cases | No direct removal, targets cells | No direct removal, shrinks tumor | No tumor removal |
| Survival Rates | Higher long-term survival when successful | Moderate impact on survival | Moderate, often requires surgery | Lower survival rates |
| Tissue Preservation | Preserves healthy surrounding tissues | May affect healthy cells | Can damage surrounding tissues | Tumor continues to grow |
| Invasiveness | Can be minimally invasive (laparoscopic) | Non-invasive | Non-invasive | No intervention |
| Pain and Discomfort | Post-op pain, but manageable | Systemic side effects (nausea) | Localized discomfort, fatigue | Possible increased discomfort |
| Recovery Time | Shorter with laparoscopic approach | Long due to multiple cycles | Varies, often combined with other | N/A |
| Recurrence Risk | Lower if tumor fully removed | Higher, may need multiple cycles | Moderate, may require surgery | High without intervention |
| Hospital Stay | Typically shorter (especially with MIS) | No stay, but regular treatments | No stay, but requires sessions | None |
| Post-Surgery Complications | Low with advanced surgical techniques | Systemic toxicity risks | Potential for tissue damage | Tumor-related complications |
